Regulation of Androgen Receptor by E3 Ubiquitin Ligases: for More or Less
Authors:
- 13 June 2014
- journal article
- Published by Smart Science and Technology, LLC in Receptors & Clinical Investigation
- Vol. 1 (5)
Abstract
Prostate cancer (PCa) primarily depends on the dysregulations of androgen receptor (AR) signaling pathway for the initiation and growth as well as recurrence after chemotherapy [1]. Androgen deprivation therapy (ADT) effectively alleviates symptoms of the malignancy to arrest further growth of primary tumors or progression of metastasis in patients with advanced PCa. However, relapse occurs in many patients after a short period, and PCa cells eventually become insensitive to ADT - termed castration resistant prostate cancer (CRPC) [2, 3]. Tremendous advancements have been achieved to decipher the mechanisms on AR signaling, and the ubiquitination machinery contributes to PCa directly or indirectly by either promotion of AR transcriptional activity or degradation of AR protein levels. The recent report reveals that SKP2 regulates AR protein through ubiquitin-mediated proteasomal degradation, highlighting the role of SKP2 in AR signaling. Given the pivotal roles of AKT and SKP2 in cancers, the differential mechanisms of AR ubiquitination by various E3 ligases hold valuable significance and beneficial implications for PCa control.Keywords
This publication has 43 references indexed in Scilit:
- ARF Represses Androgen Receptor Transactivation in Prostate CancerMolecular Endocrinology, 2013
- Phosphorylation by p38 Mitogen-Activated Protein Kinase Promotes Estrogen ReceptorαTurnover and Functional Activity via the SCFSkp2Proteasomal ComplexMolecular and Cellular Biology, 2012
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and TumorigenesisCell, 2012
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate CancerCancer Cell, 2011
- Androgen receptor levels are upregulated by Akt in prostate cancerEndocrine-Related Cancer, 2011
- Novel androgen deprivation therapy (ADT) in the treatment of advanced prostate cancerDrug Discovery Today: Therapeutic Strategies, 2010
- Akt finds its new path to regulate cell cycle through modulating Skp2 activity and its destruction by APC/Cdh1Cell Division, 2009
- Regulation of Androgen Receptor Transcriptional Activity and Specificity by RNF6-Induced UbiquitinationCancer Cell, 2009
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor GrowthCancer Research, 2008
- CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanismsBlood, 2007